42 CFR 2.36
§ 2.36 Disclosures to prescription drug monitoring programs.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 2.36, § 2.36 Disclosures to prescription drug monitoring programs, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/200352
- Permanent ID
ys:prov:200352@1- SHA-256
3f773035ce91b85e42dd63fe9834752cce0822fb66470df8539a3ad2a2c8dd32
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
A part 2 program or other lawful holder is permitted to report any SUD medication prescribed or dispensed by the part 2 program to the applicable state prescription drug monitoring program if required by applicable state law. A part 2 program or other lawful holder must obtain patient consent to a disclosure of records to a prescription drug monitoring program under § 2.31 prior to reporting of such information.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.